Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Groupe Francais De Pneumo-Cancerologie"
Count: 21
Selected: 0
NCT IDTitle
NCT05308966Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)
NCT05122806Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC
NCT05049044Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)
NCT02785562Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression.
NCT02086071Feasibility of re Biopsies at Progression
NCT03305133Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC)
NCT02293733Retrospective Study in Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR)
NCT01956331Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung Cancer
NCT00419042Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)
NCT00418704Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)
NCT00418743Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)
NCT04547504PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %
NCT02162537Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases
NCT01631136Strategies for Maintenance Therapies in Advanced Non Small Cell Lung Cancer
NCT00284778Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer
NCT05285033RW Effectiveness of Lurbinectedin in Extensive Stage SCLC
NCT02178397A Multicenter Randomized Phase III Study Comparing Second-line Treatment With Chemotherapy Associated or Not to Erlotinib in NSCLC Patients With Secondary Resistance to TKI-EGFR
NCT00651456Mesothelioma Avastin Plus Pemetrexed-cisplatin Study
NCT03801304Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer
NCT00433563Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer
NCT00037713Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG